Trulieve posts investor deck highlighting NYSE listing, US medical cannabis footprint and growth catalysts

TRULITE INC

TRULITE INC

TRUL

0.00

  • Trulieve outlined plans to list on the New York Stock Exchange on June 10, 2026 under ticker TRLV.
  • Corporate restructuring on June 3, 2026 deconsolidated mixed medical and adult-use operations into “Harvest” to support the NYSE listing.
  • Consolidated business now centers on DEA-registered, state-licensed medical operations: 206 dispensaries, 3.5 million square feet of cultivation and processing capacity.
  • Harvest holds mixed-use markets with 36 dispensaries, 0.5 million square feet of production capacity; Trulieve retains a 90% economic interest.
  • 2025 consolidated results: USD 1.2 billion revenue, 60% gross margin, USD 273 million cash flow from operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trulieve Cannabis Corp. published the original content used to generate this news brief on June 05, 2026, and is solely responsible for the information contained therein.